Long-term outcomes of cytokine therapy in pregnant women with cervical intraepithelial neoplasia

Y. Dobrokhotova, E. Borovkova, V. Romanovskaya, I.V. Stepanyants
{"title":"Long-term outcomes of cytokine therapy in pregnant women with cervical intraepithelial neoplasia","authors":"Y. Dobrokhotova, E. Borovkova, V. Romanovskaya, I.V. Stepanyants","doi":"10.32364/2618-8430-2022-5-2-106-111","DOIUrl":null,"url":null,"abstract":"Aim: to assess long-term outcomes of exogenous cytokine therapy in pregnant women with cervical intraepithelial neoplasia (CIN). Patients and Methods: this prospective study included 50 pregnant women with CIN. Women were randomized into two groups. Group 1 women (n=30, mean age 31.6±1.7 years) received vaginal suppositories with Superlymph 25 U. Group 2 women (n=20, mean age 29.8±1.4 years) received rectal suppositories with Superlymph 25 U. Cervical smear cytology (at baseline, 22 days after starting treatment, and 6 weeks after delivery), colposcopy, and cervical biopsy (at baseline and 6 weeks after delivery) were performed. Results: in group 1, cytology revealed high-grade squamous intraepithelial lesion (HSIL) in 43.3%, atypical squamous cells-cannot exclude a high-grade lesion (ASC-H) in 6.7%, and atypical squamous cells of undetermined significance (ASCUS) in 10%. In group 2, cytology revealed low-grade squamous intraepithelial lesion (LSIL) in 25%, HSIL in 45%, ASC-H in 10%, and ASCUS in 20%. After the treatment course, in group 1, a regress from HSIL to LSIL was detected in 6.7%, regress from LSIL to ASCUS in 3.3%, and regress from HSIL to ASC-H in 3.3%. In group 2, NILM was detected in 5%, a regress from HSIL to LSIL in 5%, and regress from LSIL to ASCUS in 5%. Histologically, LSIL was verified in 50% of women of both groups, CIN grade 2 in 36.7% (group 1) and 40% (group 2), CIN grade 3 in 13.3% (group 1) and 10% (group 2). Six weeks after delivery, cytological abnormalities were identified in 30 women of both groups (HSIL in 56.7% and LSIL in 43.3%). Histology detected carcinoma in situ in 3.3% and CIN grade 2–3 in 53.3%. Delivery in time (on average, at 38.4±1.1 weeks of gestation) occurred in all women. Conclusion: trend toward the improvement of cytological parameters irrespective of the mode of drug administration is reported after finishing cytokine therapy. Normalization of cytological findings was reported in 3.3% (group 1) and 5% (group 2), while improvement was reported in 6.6% (group 1) and 10% (group 2). No worsening was reported.","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"RMZh Mat'' i ditia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32364/2618-8430-2022-5-2-106-111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: to assess long-term outcomes of exogenous cytokine therapy in pregnant women with cervical intraepithelial neoplasia (CIN). Patients and Methods: this prospective study included 50 pregnant women with CIN. Women were randomized into two groups. Group 1 women (n=30, mean age 31.6±1.7 years) received vaginal suppositories with Superlymph 25 U. Group 2 women (n=20, mean age 29.8±1.4 years) received rectal suppositories with Superlymph 25 U. Cervical smear cytology (at baseline, 22 days after starting treatment, and 6 weeks after delivery), colposcopy, and cervical biopsy (at baseline and 6 weeks after delivery) were performed. Results: in group 1, cytology revealed high-grade squamous intraepithelial lesion (HSIL) in 43.3%, atypical squamous cells-cannot exclude a high-grade lesion (ASC-H) in 6.7%, and atypical squamous cells of undetermined significance (ASCUS) in 10%. In group 2, cytology revealed low-grade squamous intraepithelial lesion (LSIL) in 25%, HSIL in 45%, ASC-H in 10%, and ASCUS in 20%. After the treatment course, in group 1, a regress from HSIL to LSIL was detected in 6.7%, regress from LSIL to ASCUS in 3.3%, and regress from HSIL to ASC-H in 3.3%. In group 2, NILM was detected in 5%, a regress from HSIL to LSIL in 5%, and regress from LSIL to ASCUS in 5%. Histologically, LSIL was verified in 50% of women of both groups, CIN grade 2 in 36.7% (group 1) and 40% (group 2), CIN grade 3 in 13.3% (group 1) and 10% (group 2). Six weeks after delivery, cytological abnormalities were identified in 30 women of both groups (HSIL in 56.7% and LSIL in 43.3%). Histology detected carcinoma in situ in 3.3% and CIN grade 2–3 in 53.3%. Delivery in time (on average, at 38.4±1.1 weeks of gestation) occurred in all women. Conclusion: trend toward the improvement of cytological parameters irrespective of the mode of drug administration is reported after finishing cytokine therapy. Normalization of cytological findings was reported in 3.3% (group 1) and 5% (group 2), while improvement was reported in 6.6% (group 1) and 10% (group 2). No worsening was reported.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
宫颈上皮内瘤变孕妇细胞因子治疗的长期疗效
目的:评价外源性细胞因子治疗宫颈上皮内瘤变(CIN)孕妇的长期疗效。患者和方法:本前瞻性研究纳入了50例CIN孕妇。女性被随机分为两组。组1妇女(n=30,平均年龄31.6±1.7岁)接受阴道栓剂Superlymph 25u,组2妇女(n=20,平均年龄29.8±1.4岁)接受直肠栓剂Superlymph 25u,宫颈涂片细胞学检查(基线、开始治疗后22天、分娩后6周)、阴道镜检查和宫颈活检(基线和分娩后6周)。结果:在1组中,细胞学检查显示高级别鳞状上皮内病变(HSIL)占43.3%,不典型鳞状细胞-不能排除高级别病变(ASC-H)占6.7%,不典型鳞状细胞不确定意义(ASCUS)占10%。在第2组中,细胞学显示低级别鳞状上皮内病变(LSIL)占25%,HSIL占45%,ASC-H占10%,ASCUS占20%。疗程结束后,第1组从HSIL回归到LSIL的比例为6.7%,从LSIL回归到ASCUS的比例为3.3%,从HSIL回归到ASC-H的比例为3.3%。在第2组中,5%的人检测到NILM, 5%的人从HSIL回归到LSIL, 5%的人从LSIL回归到ASCUS。组织学上,两组均有50%的妇女被证实为LSIL, CIN 2级分别为36.7%(组1)和40%(组2),CIN 3级分别为13.3%(组1)和10%(组2)。分娩后6周,两组均有30名妇女发现细胞学异常(HSIL为56.7%,LSIL为43.3%)。组织学检出原位癌3.3%,CIN 2-3级53.3%。所有妇女均及时分娩(平均妊娠38.4±1.1周)。结论:在完成细胞因子治疗后,不论何种给药方式,细胞学参数均有改善的趋势。分别有3.3%(第1组)和5%(第2组)的患者细胞学检查结果恢复正常,而分别有6.6%(第1组)和10%(第2组)的患者出现改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.60
自引率
0.00%
发文量
14
审稿时长
12 weeks
期刊最新文献
Monitoring the puerperium microbiota is a necessary condition for diagnosing newborn infections in the early neonatal period Abnormal placentation: modern views on etiology, pathogenesis and diagnosis Gynecological aspects of sexual dysfunction in the postmenopausal women Identifying the source of peritoneal carcinomatosis by molecular biological method (a clinical case) The assessment of bone strength based on the results of ultrasound densitometry in infants born after in vitro fertilization (IVF) weighing less than 1500 g
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1